Related Experiment Video
Updated: Jan 26, 2026

Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research
Published on: June 8, 2017
LittlEARS auditory questionnaire as an infant hearing screening in Germany after the newborn hearing screening
Karolin Schaefer1, Frans Coninx2, Thomas Fischbach3
1a Department of Rehabilitation and Special Education, Faculty of Human Sciences , University of Cologne , Cologne , Germany.
Insights
The LittlEARS® Auditory Questionnaire (LEAQ®) is a feasible tool for infant hearing screening in German pediatric practices. This method successfully identified infants with permanent hearing loss, offering an alternative where objective screening is unavailable.
Area of Science:
- Pediatrics
- Audiology
- Public Health
Background:
- Infant hearing screening is crucial for early detection of hearing loss.
- Germany's current infant hearing screening program needs effective tools.
- The LittlEARS® Auditory Questionnaire (LEAQ®) offers a parent-completed screening method.
Purpose of the Study:
- To evaluate the feasibility of integrating the LEAQ® into Germany's infant hearing screening program.
- To assess the LEAQ®'s effectiveness in identifying infants with hearing impairments.
Main Methods:
- The LEAQ® was administered to 5316 infants (9-14 months) across 47 pediatric practices.
- Infants failing initial or rescreening were referred to specialists.
- A 3-year follow-up was conducted on infants who failed and a control group.
Main Results:
- Six infants with permanent hearing loss were identified using the LEAQ®.
- The questionnaire proved easily implementable in pediatric settings.
Conclusions:
- The LEAQ® is a viable screening tool for infant hearing in Germany.
- It serves as a potential alternative to objective screening methods, especially where those are unavailable.
- The LEAQ® can monitor infant hearing development and detect late-onset or progressive hearing loss.
Abstract:
Objective: To investigate the feasibility of using the LittlEARS® Auditory Questionnaire (LEAQ®) as part of the infant hearing screening programme in Germany. Design: LEAQ®s were distributed to 47 paediatric practices and were completed by the parents/guardians of the infants (aged between 9-14 months) involved in the study (= LEAQ® screening). The infants who failed the LEAQ® screening were invited to a LEAQ rescreening. Infants who failed the LEAQ® rescreening were sent to a paediatric ENT specialist. After 3 years, a follow-up was performed on two groups: the first group comprised infants who failed the LEAQ screening; the second group (control group) comprised 200 infants who passed the LEAQ screening. Study Sample: 5316 questionnaires were returned. Results: Six infants with permanent hearing loss were identified using the LEAQ® as a screening tool. Conclusions: An infant hearing screening using the LEAQ® is easily implementable in paediatric practices and may be a good alternative in countries where no objective screening instruments are available. The LEAQ® was suitable for monitoring hearing development in infants in general and could help to identify a late-onset or progressive hearing loss in infants.
More Related Videos
Related Concept Videos
Hearing
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
The Auditory Ossicles
The aptly named stapes look very much like a stirrup. The three ossicles are unique to mammals, and each plays a role in...
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
Auditory Perception
Drug Dosing: Infants and Children

